Rabbit anti-Mouse, Rat ARIP2B Polyclonal Antibody | anti-ARIP2B antibody

ARIP2B Antibody FITC Conjugated

Cat. Num. AAA9460052

• Reactivity: Mouse, Rat
• Applications: Immunofluorescence
• Purity: Purified by Protein A
• Synonyms: ARIP2B; Polyclonal Antibody; ARIP2B Antibody FITC Conjugated; Activin receptor type-2B; Activin receptor type IIB; ACTR-IIB; Acvr2b; Actriib; anti-ARIP2B antibody

• Host: Rabbit
• Reactivity: Mouse, Rat
• Clonality: Polyclonal
• Isotype: IgG
• Purity/Purification: Purified by Protein A
• Form/Format: 10mM Tris Buffered Saline containing 1% BSA, 50% glycerol and 0.09% sodium azide.
• Concentration: 1mgml (varies by lot)

• Applicable Applications for anti-ARIP2B antibody: Immunofluorescence (IF)
• Application Notes: IF: 1:50-200
• Conjugation: FITC
• Excitation Emission: 494nm 518nm
• Immunogen: KLH conjugated synthetic peptide aa 300-350 512 derived from rat ARIP2B
• Preparation and Storage: Store at 4 degree C for 12 months.

Related Product Information for anti-ARIP2B antibody

Transmembrane serine threonine kinase activin type-2 receptor forming an activin receptor complex with activin type-1 serine threonine kinase receptors (ACVR1, ACVR1B or ACVR1c). Transduces the activin signal from the cell surface to the cytoplasm and is thus regulating many physiological and pathological processes including neuronal differentiation and neuronal survival, hair follicle development and cycling, FSH production by the pituitary gland, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. Activin is also thought to have a paracrine or autocrine role in follicular development in the ovary. Within the receptor complex, the type-2 receptors act as a primary activin receptors (binds activin-A INHBA, activin-B INHBB as well as inhibin-A INHA-INHBA). The type-1 receptors like ACVR1B act as downstream transducers of activin signals. Activin binds to type-2 receptor at the plasma membrane and activates its serine-threonine kinase. The activated receptor type-2 then phosphorylates and activates the type-1 receptor. Once activated, the type-1 receptor binds and phosphorylates the SMAD proteins SMAD2 and SMAD3, on serine residues of the C-terminal tail. Soon after their association with the activin receptor and subsequent phosphorylation, SMAD2 and SMAD3 are released into the cytoplasm where they interact with the common partner SMAD4. This SMAD complex translocates into the nucleus where it mediates activin-induced transcription. Inhibitory SMAD7, which is recruited to ACVR1B through FKBP1A, can prevent the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal. Activin signal transduction is also antagonized by the binding to the receptor of inhibin-B via the IGSF1 inhibin coreceptor (By similarity).

Product Categories/Family for anti-ARIP2B antibody

Conjugated Primary Antibodies

NCBI and Uniprot Product Information

• NCBI GI #: 67514518
• NCBI GeneID: 25366
• NCBI Accession #: NP_113742.1
• NCBI GenBank Nucleotide #: NM_031554.1
• UniProt Accession #: P38445; Q4V8J8
• Molecular Weight: 57,857 Da
• NCBI Official Full Name: activin receptor type-2B
• NCBI Official Synonym Full Names: activin A receptor type 2B
• NCBI Official Symbol: Acvr2b
• NCBI Protein Information: activin receptor type-2B
• UniProt Protein Name: Activin receptor type-2B
• UniProt Gene Name: Acvr2b
• UniProt Synonym Gene Names: Actriib; ACTR-IIB

NCBI Description

plays a role in reproductive physiology and endocrinology [RGD, Feb 2006]

Uniprot Description

ACVR2B: a tyrosine-kinase like receptor kinase of the STKR family. The holoreceptor receptor is a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. Each is composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic kinase domain. Type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptor kinases are apparently constitutively active. The IIB receptor displays a 3- to 4-fold higher affinity for activin A than the II receptor.

Protein type: EC 2.7.11.30; Kinase, protein; Membrane protein, integral; Protein kinase, Ser/Thr (receptor); Protein kinase, TKL; STKR family; TKL group; Type2 subfamily

Chromosomal Location of Human Ortholog: 8q32

Cellular Component: cytoplasm; integral component of membrane; plasma membrane; protein complex; receptor complex

Molecular Function: activin binding; ATP binding; growth factor binding; metal ion binding; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; signal transducer, downstream of receptor, with serine/threonine kinase activity; transforming growth factor beta binding; transmembrane receptor protein serine/threonine kinase activity

Biological Process: activation of protein kinase activity; activin receptor signaling pathway; anterior/posterior pattern specification; blood vessel remodeling; BMP signaling pathway; determination of left/right symmetry; embryonic foregut morphogenesis; gastrulation with mouth forming second; heart development; insulin secretion; kidney development; lung development; lymphangiogenesis; mesoderm development; negative regulation of transcription from RNA polymerase II promoter; odontogenesis of dentine-containing teeth; organ growth; palate development; pancreas development; pattern specification process; positive regulation of activin receptor signaling pathway; positive regulation of bone mineralization; positive regulation of osteoblast differentiation; post-embryonic development; protein amino acid phosphorylation; regulation of signal transduction; regulation of transcription, DNA-templated; response to glucose stimulus; sexual reproduction; signal transduction; skeletal morphogenesis; skeletal system development; transmembrane receptor protein serine/threonine kinase signaling pathway